Literature DB >> 12165455

Aneuploidy theory explains tumor formation, the absence of immune surveillance, and the failure of chemotherapy.

David Rasnick1.   

Abstract

The autocatalyzed progression of aneuploidy accounts for all cancer-specific phenotypes, the Hayflick limit of cultured cells, carcinogen-induced tumors in mice, the age distribution of human cancer, and multidrug-resistance. Here aneuploidy theory addresses tumor formation. The logistic equation, phi(n)(+1) = rphi(n) (1 - phi(n)), models the autocatalyzed progression of aneuploidy in vivo and in vitro. The variable phi(n)(+1) is the average aneuploid fraction of a population of cells at the n+1 cell division and is determined by the value at the nth cell division. The value r is the growth control parameter. The logistic equation was used to compute the probability distribution for values of phi after numerous divisions of aneuploid cells. The autocatalyzed progression of aneuploidy follows the laws of deterministic chaos, which means that certain values of phi are more probable than others. The probability map of the logistic equation shows that: 1) an aneuploid fraction of at least 0.30 is necessary to sustain a population of cancer cells; and 2) the most likely aneuploid fraction after many population doublings is 0.70, which is equivalent to a DNA(index)=1.7, the point of maximum disorder of the genome that still sustains life. Aneuploidy theory also explains the lack of immune surveillance and the failure of chemotherapy.

Entities:  

Mesh:

Year:  2002        PMID: 12165455     DOI: 10.1016/s0165-4608(01)00665-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  Sporadic aneuploidy in PHA-stimulated lymphocytes of Turner's syndrome patients.

Authors:  Orit Reish; Nirit Brosh; Rima Gobazov; Malka Rosenblat; Vitalia Libman; Maya Mashevich
Journal:  Chromosome Res       Date:  2006-07-12       Impact factor: 5.239

2.  The Greater Genomic Landscape: The Heterogeneous Evolution of Cancer.

Authors:  Luay M Almassalha; Greta M Bauer; John E Chandler; Scott Gladstein; Igal Szleifer; Hemant K Roy; Vadim Backman
Journal:  Cancer Res       Date:  2016-08-22       Impact factor: 12.701

3.  Congenital Aneuploidy in Klinefelter Syndrome with B-Cell Acute Lymphoblastic Leukemia Might Be Associated with Chromosomal Instability and Reduced Telomere Length.

Authors:  Eigil Kjeldsen
Journal:  Cancers (Basel)       Date:  2022-05-06       Impact factor: 6.575

4.  Selection and adaptation during metastatic cancer progression.

Authors:  Christoph A Klein
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

Review 5.  Centrosome and retroviruses: the dangerous liaisons.

Authors:  Philippe V Afonso; Alessia Zamborlini; Ali Saïb; Renaud Mahieux
Journal:  Retrovirology       Date:  2007-04-14       Impact factor: 4.602

6.  Towards a theory of biological robustness.

Authors:  Hiroaki Kitano
Journal:  Mol Syst Biol       Date:  2007-09-18       Impact factor: 11.429

Review 7.  Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer.

Authors:  Jermaine Coward; Angus Harding
Journal:  Front Oncol       Date:  2014-05-26       Impact factor: 6.244

8.  Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia.

Authors:  Siddhartha Ganguly; Trisha Home; Abdulraheem Yacoub; Suman Kambhampati; Huidong Shi; Prasad Dandawate; Subhash Padhye; Ashok K Saluja; Joseph McGuirk; Rekha Rao
Journal:  Oncotarget       Date:  2015-10-13

Review 9.  Cancer heterogeneity: converting a limitation into a source of biologic information.

Authors:  Albert Rübben; Arturo Araujo
Journal:  J Transl Med       Date:  2017-09-08       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.